Zhejiang Starry Pharm Co Ltd (603520) — Long-term Investment Intensity
Zhejiang Starry Pharm Co Ltd (603520) has a Long-term Investment Intensity of 0.6% as of September 2019. Long-term investments of CN¥20.15 Million represent 0.6% of total assets of CN¥3.42 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 603520 total equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Zhejiang Starry Pharm Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Zhejiang Starry Pharm Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 0.6%, reflecting long-term investments of CN¥20.15 Million against total assets of CN¥3.42 Billion CNY. Also explore 603520 total asset value for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Zhejiang Starry Pharm Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Zhejiang Starry Pharm Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 603520 market cap overview.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.6% | CN¥18.32 Million | CN¥3.07 Billion | ▼ -0.3 pp |
| 2017 | 0.9% | CN¥18.18 Million | CN¥2.01 Billion | ▼ -0.2 pp |
| 2016 | 1.1% | CN¥21.41 Million | CN¥1.89 Billion | ▲ +0.9 pp |
| 2015 | 0.2% | CN¥3.00 Million | CN¥1.48 Billion | — |